FDG PET
FDG PET is the standard PET scan. A radioactive sugar shows which tissues are burning glucose fast, which most cancers do.
18F-fluorodeoxyglucose exploits the Warburg effect. Standard for staging and response in lymphoma (Deauville), lung, melanoma, head and neck, oesophageal cancer. Weak in prostate, low-grade neuroendocrine, mucinous, and some breast cancers, which is why target-specific tracers exist.
How it works
FDG is taken up via GLUT transporters and trapped after phosphorylation by hexokinase.
- Universal availability
- Decades of validation
- Non-specific: infection and inflammation are also hot
- Brain background
- Poor in indolent tumours
Latest papers
topQuery for this technology: (TITLE:"FDG PET" OR ABSTRACT:"FDG PET" OR TITLE:"18F-FDG PET/CT" OR ABSTRACT:"18F-FDG PET/CT") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about FDG PET, not a curated reading list.
Pages like this
not linked directly; found by shared links- PathwayKEAP1–NRF2 antioxidant pathway
Shares Map metabolic dependencies in the patient, not the dish, Hallmark: reprogramming cellular metabolism, Glutamine addiction, Cancer metabolism.
- PairingCaution: bleomycin lung toxicity, especially with brentuximab or G-CSF
Shares RATHL, PET-adapted (response-adapted) therapy, Hodgkin lymphoma.
- PathwayNutrient competition & metabolic immunosuppression
Shares Hypoxia-activated prodrugs, Warburg effect, Glutamine addiction, Cancer metabolism.
- InstitutionGerman Lymphoma Alliance
Shares German Hodgkin Study Group, LYSA – The Lymphoma Study Association, Diffuse large B-cell lymphoma.
- TrialGHSG HD21
Shares PET-adapted (response-adapted) therapy, German Hodgkin Study Group, Hodgkin lymphoma.
- InstitutionNordic Lymphoma Group
Shares International Extranodal Lymphoma Study Group, Hodgkin lymphoma, Diffuse large B-cell lymphoma.
- InstitutionHOVON
Shares International Extranodal Lymphoma Study Group, Hodgkin lymphoma, Multiple myeloma, Diffuse large B-cell lymphoma.
- ProductPertuzumab
Shares Early FDG-PET response → chemotherapy omission (HER2+), PHERGain, HER2-positive breast cancer.